Watch the video below, which gives an overview of the role of PCSK9 in cholesterol homeostasis through regulation of low-density lipoprotein receptor (LDLR) degradation.
View the video below and download the associated materials relating to the role of PCSK9 in the regulation of LDL-C here.
View this interactive artery showing the progression of atherosclerosis and plaque vulnerability.
Do you know the low-density lipoprotein cholesterol LDL-C levels of patients with high-risk CVD in your area? View this Cholesterol Heat.
Watch how LDL-C levels recommended by multiple ccholesterol guidelines have decreased over time and understand current recommendations for patients with very high-risk ASCVD..
Learn how you can better manage cholesterol in patients with high-risk ACS and help reduce the risk of subsequent cardiovascular events.
Watch experts discuss current cholesterol guidelines, discharge protocol, and routine follow-up in patients with recent MI.
Watch experts discuss the HCP/patient conversation regarding the importance of LDL-C lowering for patients with recent MI.
Click here to view the American College of Cardiology/American Heart Association Task Force guidelines for the management of blood cholesterol.
Click here to view the 2019 European Society of Cardiology and European Atherosclerosis Society Task Force guidelines for the management of dyslipidemia.
Click here to view the American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for the management of dyslipidemia and prevention of CVD.
Click here to view the American College of Cardiology's ECDP guidance on the role of non-statin therapies for LDL-C lowering in the management of ASCVD risk.
Download this overview that explains the scientific progression of atherosclerosis and ASCVD, and includes recent clinical guidelines for the treatment of patients with very high-risk ASCVD.
